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ABSTRACT 
The Panel on Food Additives and Nutrient Sources added to Food (ANS) delivers a scientific opinion re-
evaluating the safety of carnauba wax (E 903). Carnauba wax (E 903) is authorised in the EU as food additive as 
glazing agent. It has been evaluated by the Scientific Committee on Food (SCF) and by the Joint FAO/WHO 
Expert Committee on Food Additives (JECFA) who allocated an Acceptable Daily Intake (ADI) of 7 mg/kg 
bw/day. The SCF did not establish an ADI but considered the use of carnauba wax as a glazing agent 
acceptable. Carnauba wax is a complex mixture of compounds consisting mainly of aliphatic esters (wax esters), 
α-hydroxyl esters and cinnamic aliphatic diesters obtained from the Brazilian Mart wax palm, Copernicia 
cerifera. The Panel considered that carnauba wax would be predicted to not be significantly absorbed from the 
diet and that if hydrolysed its main constituents could be absorbed and incorporated into normal cellular 
metabolic pathways. Based on the available data and the lack of structural alerts on carnauba wax it was 
concluded that there is no concern for genotoxicity for carnauba wax. Subchronic and reproductive and 
developmental toxicity studies did not showed adverse effects related to carnauba wax intake. No chronic 
toxicity or carcinogenicity studies were available on carnauba wax. Overall, the Panel considered that long-term 
toxicity data on carnauba wax were lacking and therefore did not establish an ADI.. However, the Panel 
considered that the exposure estimates to carnauba wax from the proposed uses resulted in sufficient margins of 
safety compared to the identified No Observed Adverse Effect Levels (NOAELs) for carnauba wax, allowing 
the Panel to conclude that the use of carnauba wax as a food additive with the currently authorised uses would 
not be of safety concern. 
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SUMMARY 
Following a request from the European Commission, the Panel on Food Additives and Nutrient 
Sources added to Food (ANS) of the European Food Safety Authority (EFSA) was asked to deliver a 
scientific opinion on the re-evaluation of carnauba wax (E 903) as a food additive. 
The Panel was not provided with a newly submitted dossier and based its evaluation on previous 
evaluations, additional literature that became available since then and the data available following a 
public call for data. The Panel noted that not all original studies on which previous evaluations were 
based were available for re-evaluation by the Panel.  
Carnauba wax is authorised in the EU as a food additive only as glazing agent (Directive 95/2/CE
4; 
Regulation 2008). Carnauba wax is authorised to food supplements, small products of fine bakery 
wares coated with chocolate, snacks, nuts and coffee beans. Maximum permitted use is 200 mg/kg 
food. It is also permitted as surface treatment on fresh citrus fruits, melons, apples and pears, as well 
as on peaches and pineapples up to 200 mg/kg food. In confectionary it may be used up to 500 mg/kg 
and on chewing gum up to 1200 mg/kg.  
Carnauba wax has been evaluated by the Scientific Committee on Food (SCF, 1992; 1997; 2001; 
2002) and by the Joint FAO/WHO Expert Committee on Food Additives (JECFA, 1993). JECFA 
allocated an Acceptable Daily Intake (ADI) of 0-7 mg/kg bw/day (JECFA, 1993). The SCF did not 
establish an ADI but did not object the use of carnauba wax as a glazing agent (SCF, 2002).  
Carnauba wax is a complex mixture of compounds consisting of aliphatic esters (wax esters), α-
hydroxyl esters and cinnamic aliphatic diesters. It also contains free acids, free alcohols, hydrocarbons 
and resins. It is obtained from the leaves of the Brazilian Mart wax palm, Copernicia cerifera (EU, 
2008). The average composition of the highest quality carnauba wax has been reported as consisting 
primarily of 40% (w/w) aliphatic esters, 21% (w/w) diesters of 4-hydroxycinnamic acid, 13% (w/w) 
esters of ω-hydroxycarboxylic acids and 12% (w/w) free alcohols (Wolfmeier et al., 2005).  
Specifications have been defined in the Directive 2008/84/EC and new specifications according to 
Commission Regulation (EU) No 231/2012 will apply from 1
st December 2012. No new data on 
absorption, distribution, metabolism and elimination were available for this revaluation. One modified 
90-day toxicity feeding study carried out to investigate “bioaccumulation” of carnauba wax in Fischer 
F-344 rats indirectly suggested that the lipid like components from the wax are not accumulated in the 
tissues (Edwards, 1998). Overall, taking also into consideration the chemical composition of carnauba 
wax, the Panel considered, as with other natural waxes, that absorption of carnauba wax is expected to 
be low, if any. 
The Panel noted that toxicological studies were conducted on carnauba wax itself and therefore the 
components of carnauba wax have been tested in those studies. 
From a 13-weeks study with Wistar rats fed diets containing 0, 1, 5 or 10% carnauba wax, or 10% 
cellulose powder for 13 weeks corresponding to 0, 800, 4200 and 8800 mg/kg bw/day for males and 0, 
900, 4600 and 10 200 mg/kg bw/day for females (Rowland et al., 1982) the Panel could derive a No 
Observed Adverse Effect Level (NOAEL) of 8800 mg/kg bw/day, the highest dose tested in male rats. 
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From a 90-day toxicity study with Fischer F-344 rats fed diets containing carnauba wax corresponding 
to daily intakes of 0, 15, 150 and 1500 mg/kg bw, respectively, continuously for 90 days (Edwards, 
1998), the Panel could derive a NOAEL of 1500 mg/kg bw/day, the highest dose tested. 
The Panel considered that based on the available data and the lack of structural alerts on carnauba wax 
it can be concluded that there is no concern for genotoxicity for carnauba wax.  
No chronic toxicity or carcinogenicity studies were available on carnauba wax. 
From a reproductive toxicity study of carnauba wax with Wistar rats administered 0, 0.1, 0.3, or 1% 
carnauba wax in the diet, the Panel could derive a NOAEL of approximately 670 mg carnauba wax/kg 
bw/day, the highest dose tested in female rats.  
Refined estimates reported for carnauba wax, when considering Maximum Permitted Levels (MPLs), 
resulted in a mean dietary exposure of European toddlers (aged 12-35 months and weighing an 
average of 15 kg) ranged from 2.6-4.6 mg/kg bw/day, and from 3.1-8.1 mg/kg bw/day at the 95
th 
percentile. The mean dietary exposure of European children (aged 3-9 years and weighing an average 
of 30 kg) ranged from 1.6-4.5 mg/kg bw/day, and from 3.2-7.6 mg/kg bw/day at the 95
th percentile. 
The main contributors to the total anticipated mean exposure to carnauba wax for these populations 
were fruits and confectionary. 
The mean dietary exposure of European adolescents (aged 10-17 years and weighing an average of 50 
kg) ranged from 0.9-2.1 mg/kg bw/day, and from 1.9-3.8 mg/kg bw/day at the 95
th percentile. The 
main contributors to the total anticipated mean exposure to carnauba wax for this population were 
fruits and confectionary. Whereas the mean dietary exposure of the European adult population give a 
mean dietary exposure in the range of 0.7-1.7 mg/kg bw/day and 1.5-3.0 mg/kg bw/day for high level 
consumers. The main contributors to the total anticipated mean exposure to carnauba wax for this 
population were fruits. For the elderly, mean exposure to carnauba wax was in the range of 0.8-1.5 
mg/kg bw/day and in the range of 1.9-2.7 mg/kg bw/day at the 95
th percentile. Main contributors for 
these populations were fruits. From the highest consumers of these populations (95
th percentile) these 
exposures estimates would result in margins of safety from 83 to 447 when compared to the NOAEL 
of 670 mg/kg bw/day identified in a reproductive toxicity study with rats by Parent (Parent et al., 
1983), from 31 to 67 when compared to the NOAEL of 250 mg/kg bw/day identified in a subchronic 
toxicity study with dogs by Parent (Parent et al., 1983b), from 185 to 1000 when compared to the 
NOAEL of 1500 mg/kg bw/day identified in a subchronic toxicity study with rats by Edwards 
(Edwards et al., 1998), and from 1086 to 5867 when compared to the NOAEL of 8800 mg/kg bw/day 
identified in a subchronic toxicity study with rats by Rowland (Rowland et al., 1982). These margins 
of safety are considered sufficient by the Panel taking into consideration that the NOAEL’s identified 
are the highest dose tested not showing any effect in their respective studies, and that the exposure 
estimates to carnauba wax carried out in this opinion are very conservative. 
Overall, the Panel concluded that long-term toxicity data on carnauba wax were lacking and therefore 
did not establish an ADI. 
However, the Panel noted that available toxicity studies consistently reported no findings associated 
with carnauba wax intake. Furthermore, consideration of the conservative exposure estimates to 
carnauba wax from the currently authorised uses indicated sufficient margins of safety, which allowed 
the Panel to consider that the use of carnauba wax as a food additive with the currently authorised uses 
would not be of safety concern. Re-evaluation of Carnauba wax (E 903) 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food additives 
requires that food additives are subject to a safety evaluation by the European Food Safety Authority 
(EFSA) before they are permitted for use in the European Union. In addition, it is foreseen that food 
additives must be kept under continuous observation and must be re-evaluated by EFSA.  
For this purpose, a programme for the re-evaluation of food additives that were already permitted in 
the European Union before 20 January 2009 has been set up under the Regulation (EU) No 257/2010
5. 
This Regulation also foresees that food additives are re-evaluated whenever necessary in light of 
changing conditions of use and new scientific information. For efficiency and practical purposes, the 
re-evaluation should, as far as possible, be conducted by group of food additives according to the main 
functional class to which they belong. 
The order of priorities for the re-evaluation of the currently approved food additives should be set on 
the basis of the following criteria: the time since the last evaluation of a food additive by the Scientific 
Committee on Food (SCF) or by EFSA, the availability of new scientific evidence, the extent of use of 
a food additive in food and the human exposure to the food additive taking also into account the 
outcome of the Report from the Commission on Dietary Food Additive Intake in the EU
6 of 2001. The 
report “Food additives in Europe 2000
7” submitted by the Nordic Council of Ministers to the 
Commission, provides additional information for the prioritisation of additives for re-evaluation. As 
colours were among the first additives to be evaluated, these food additives should be re-evaluated 
with a highest priority. 
In 2003, the Commission already requested EFSA to start a systematic re-evaluation of authorised 
food additives. However, as a result of adoption of Regulation (EU) 257/2010 the 2003 Terms of 
References are replaced by those below. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The Commission asks the European Food Safety Authority to re-evaluate the safety of food additives 
already permitted in the Union before 2009 and to issue scientific opinions on these additives, taking 
especially into account the priorities, procedures and deadlines that are enshrined in the Regulation 
(EU) No 257/2010 of 25 March 2010 setting up a programme for the re-evaluation of approved food 
additives in accordance with the Regulation (EC) No 1333/2008 of the European Parliament and of the 
Council on food additives.  
                                                      
 
5 OJ L 80, 26.03.2010, p19 
6 COM(2001) 542 final. 
7 Food Additives in Europe 2000, Status of safety assessments of food additives presently permitted in the EU, Nordic 
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ASSESSMENT 
1.  Introduction 
The present opinion deals with the re-evaluation of the safety of carnauba wax (E 903) when used as a 
food additive. 
Carnauba wax (E 903) is authorised in the EU as food additive, as glazing agent only (Directive 
95/2/CE
8; EU Regulation 1333/2008
9). It has been evaluated by the Scientific Committee on Food 
(SCF, 1992; 1997; 2001; 2002) and by the Joint FAO/WHO Expert Committee on Food Additives 
(JECFA, 1993). JECFA allocated an Acceptable Daily Intake (ADI) of 0 - 7 mg/kg bw/day (JECFA, 
1993). The SCF did not establish an ADI but did not object to the use of carnauba wax as a glazing 
agent (SCF, 2002). SCF concluded that the use of carnauba wax was up to 1200 mg/kg of food would 
yield a worst-case intake estimate of 48 mg/person/day (equivalent to 4.8 mg/kg bw/day for 10 kg 
child, or less for an adult) and these levels were within the ADI of 0 - 7 mg/kg bw/day set by JECFA 
(SCF, 2002). Carnauba wax was also reviewed by TemaNord in 2002 (TemaNord, 2002).  
The Panel was not provided with a newly submitted dossier and based its evaluation on previous 
evaluations and reviews, additional literature that became available since then and the data available 
following a public call for data
10. The Panel noted that not all original studies on which previous 
evaluations or reviews were based were available for re-evaluation by the Panel.  
2.  Technical data  
2.1.  Identity of the substance 
Carnauba wax is obtained from the leaf buds and leaves of the Brazilian Mart wax palm, Copernicia 
cerifera (Directive 2008/84/EC)
11. It has the CAS Registry Number 8015-86-9. 
Recognized classification of carnauba wax types has been adopted internationally and according to 
Wolfmeier et al. (2005) it goes from a highest value prime product (Type 1 or prime yellow) to a very 
crude product (Type 4 or fatty gray/filtered). According to these authors, chemically refined or 
derivatized carnauba waxes are no longer available commercially. 
JECFA describes carnauba wax as a complex mixture consisting of aliphatic esters (wax esters), α-
hydroxyl esters and cinnamic aliphatic diesters. It also contains free acids, free alcohols, hydrocarbons 
and resins (JECFA, 1998). Aliphatic esters are described by JECFA as consisting of straight-chain 
acids with even-numbered carbon chains from C24 to C28 and straight-chain alcohols with even-
numbered carbon chains from C30 to C34. Αlpha-hydroxyl esters are described as consisting of straight-
chain hydroxyl acids with even-numbered carbon chains from C22 to C28, straight-chain acids with 
even-numbered carbon chains form C24 to C28, straight-chain monohydric alcohols with even-
numbered carbon chains from C24 to C34 and dihydric alcohols with even-numbered carbon chains 
from C24 to C34. Cinnamic aliphatic esters are described as consisting of p-methoxycinnamic acid and 
dihydric alcohols with even-numbered carbon chains from C24 to C34 (JECFA, 1998).  
                                                      
 
8 European Parliament and Council Directive 95/2/EC of 20 February 1995 on food additives other than colours and 
sweeteners. OJ L 61, 18.3.1995, p. 1-40. 
9 Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives. OJ 
L 354, p 16-33. 
10 Call for scientific data on miscellaneous waxes permitted as food additives in the EU (published: 23 November 2009). 
Available from:  http://www.efsa.europa.eu/en/dataclosed/call/ans091123b.htm 
11 Commission Directive 2008/84/EC of 27 August 2008 laying down specific purity criteria on food additives other than 
colours and sweeteners. OJ L 253, 20.9.2008, p. 1-175. Re-evaluation of carnauba wax (E 903) as a food addtive 
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Free-acids are described as straight-chain acids with even-numbered carbon chains from C24 to C28, 
free alcohols are described as straight-chain alcohols with even-numbered carbon chains from C30 to 
C34 and hydrocarbons are described as straight-chain odd-numbered carbon chains from C27 to C31 
(JECFA, 1998). The Panel noted that hydrocarbons would only constitute between 0.3 and 1% of the 
total composition of carnauba wax. 
The average composition of the highest quality carnauba wax is reported in Table 1. 
Table 1:  Composition of yellow carnauba wax according to Vandenburg et al. (1970). 
Compound Amount 
(wt% of wax) 
Aliphatic esters  38-40 
Diesters of 4-hydroxycinnamic acid  20-23 
Diesters of 4-methoxycinnamic acid  5-7 
Esters of ω-hydroxycarboxylic acids  12-14 
Free alcohols  10-12 
Free acids  5-7 
Hydrocarbons
12 (paraffins)  0.3-1 
Triterpene diols  0.4 
 
Carnauba wax is one of the hardest and highest-melting point natural waxes. At room temperature the 
wax has a weakly aromatic odour and a characteristic hay-like scent in the molten state (Wolfmeier et 
al., 2005). It is identified as being insoluble in water, sparingly soluble in alcohol, but very soluble in 
chloroform and ether (Commission Regulation (EU) No 231/2012
13).  
Two synonyms are palm wax and Brazilian wax. 
2.2.  Specifications 
Specifications have been defined in the Directive 2008/84/EC and new specifications according to 
Commission Regulation (EU) No 231/2012 will apply from 1 December 2012. Specifications have 
also been defined by JECFA (JECFA, 1998) (Table 2). 
Table 2:  Specifications for carnauba wax according to Commission Regulation (EU) No 
231/2012and JECFA (1998). 
  Commission Regulation (EU)  
No 231/2012 
JECFA, (1998) 
DEFINITION  Carnauba wax is a purified wax 
obtained from the leaf buds and 
leaves of the Brazilian Mart wax 
palm, Copernicia cerifera 
The refined wax obtained from 
the fronds of the Brazilian 
tropical palm tree Copernicia 
cerifera (Arruda) Mart. [syn. C. 
purnifera (Muell.)] 
DESCRIPTION  Light brown to pale yellow powder 
or flakes or hard and brittle solid 
with a resinous fracture 
A pale yellow to light brown, 
hard and brittle solid, having a 
clean fracture 
                                                      
 
12 Hydrocarbons are defined as organic compounds consisting entirely of hydrogen and carbon, 
13 Commission Regulation (EU) No 231/2012 of 9 March 2012 laying down specifications for food additives listed in 
Annexes II and III to Regulation (EC) No 1333/2008 of the European Parliament and of the Council. OJ L 83, 22.3.2012, p 
1-295. Re-evaluation of carnauba wax (E 903) as a food addtive 
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FUNCTIONAL USES  -  Glazing agent, bulking agent, 
acidity regulator, carrier 
IDENTIFICATION    
Solubility   Insoluble in water, partly soluble in 
boiling ethanol, soluble in 
chloroform and diethyl ether
Insoluble in water, partially 
soluble in boiling ethanol, soluble 
in ether 
Melting range  Between 82
oC and 86
oC 80 – 86 ºC 
Specific gravity  About 0.997 - 
PURITY    
Sulphated ash  Not more than 0.25% Not more than 0.25% w/w
Acid value
14  Not less than 2 and not more than 7 Between 2 and 7 
Ester value
15  Not less than 71 and not more than 
88 
Between 71 and 93 
Unsaponifiable matter  Not less than 50% and not more 
than 55% 
Between 50% and 55% 
Saponification value
16  -  Between 78 and 95 
Lead  Not more than 2 mg/kg  Not more than 2 mg/kg 
Arsenic  Not more than 3 mg/kg  - 
Mercury  Not more than 1 mg/kg  - 
 
The Panel noted minor differences between JECFA and EU specifications for carnauba wax. 
2.3.  Manufacturing Process  
Carnauba wax is obtained from the leaves of the palm Copernicia cerifera. The wax is located on the 
outer palm leaves. After drying the leaves in the sun or on steam-heated racks, the wax is removed 
(loosened) from the leaves manually or mechanically. The dried leaves are chopped and the loosened 
wax chips are separated by an air classification process to give a mixture of approximately 60% wax 
and 40% chopped leaves. The primary purification process of the mixture involves melting in water 
with oxalic acid which gives a crude wax paste. The latter is heated to its boiling point and pressed 
through a filter while hot. Centrifugation of the filtrate gives virtually anhydrous wax. The remaining 
wax can be extracted from the dried filter cake with solvents (e.g. heptane). The crude product is 
normally supplied in lumps. Additional bleaching with hydrogen peroxide can also be carried out 
(Wolfmeier et al., 2005).  
2.4.  Methods of analysis in foods 
The analysis of carnauba wax itself is a difficult analytical challenge, although by means of flash 
heating the wax sample and simultaneous derivatisation, the high molecular weight esters, can be 
hydrolysed and converted to their methyl derivatives. Subsequent Gas chromatography–mass 
spectrometry (GC-MS) analysis results in characteristic fingerprint patterns and identification of 
marker compounds for carnauba wax (Asperger et al., 1999). Although in principle selective 
extraction of the wax from food systems might be possible, similar compounds originating from 
sources other than carnauba wax will undoubtedly complicate an already complex analysis. Solvent 
extraction of carnauba wax from rodent diets, silica gel clean-up and analysis by Fourier transform 
infra-red spectroscopy (FT-IR) has been successfully applied over the concentration range 0.01 to 
2.5% wax in the diet (Walters, 1998). For the specific situation of wax coatings on apples, differential 
                                                      
 
14 The Acid Value (AV) is defined as the mass of KOH (in mg) required to neutralise the acid groups contained in 1 g Dry 
Substance (DS). 
15 The ester value is defined as the number of mg of potassium hydroxide (KOH) required to saponify the esters in 1 g of a 
sample. 
16 The saponification value is defined as the number of mg of potassium hydroxide (KOH) to saponify the esters in 1 g of the 
sample and neutralize the free acids in 1 g of a sample. Re-evaluation of carnauba wax (E 903) as a food addtive 
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scanning calorimetry has been applied using the characteristic peak maximum temperature of the wax 
for identification of the wax treatment agent (Ritter et al., 2001). 
Alkaline hydrolysis, gas-liquid chromatography and thin layer chromatography have also been 
described as analytical methods (Anonymous, 1984). 
2.5.  Reaction and fate in foods, stability 
No specific documentation has been submitted or found in the open literature, but as the components 
of carnauba wax are rather inert and stable it can be assumed that degradation or reaction with food 
components will not take place at significant extent. 
2.6.  Case of need and proposed uses 
According to Directive 95/2/EC
17 carnauba wax is permitted only as a glazing agent to food 
supplements, small products of fine bakery wares coated with chocolate, snacks, nuts and coffee 
beans. Maximum permitted use is 200 mg/kg food. It is also permitted as surface treatment on fresh 
citrus fruits, melons, apples and pears as well as on peaches and pineapples up to 200 mg/kg food. In 
confectionary it may be used up to 500 mg/kg and on chewing gum up to 1200 mg/kg.  
These use levels were confirmed as a response to the EFSA call on new data in connection with the 
present re-evaluation process. 
No information on use levels or use frequency has been submitted or found in the literature search 
concerning the use on fruits.  
Table 3 summarises those foodstuffs that are permitted to contain carnauba wax up to specified 
Maximum Permitted Levels (MPLs) set by Directive 95/2/EC. 
Table 3:  Maximum Permitted Levels of use of carnauba wax in foodstuffs according to the 
European Parliament and Council Directive 95/2/EC and maximum reported use levels of 
Carnauba wax in foodstuffs used for the refined exposure assessment 
Foodstuffs 
Maximum 
Permitted Level 
(mg/kg) 
Maximum 
reported use level 
(mg/kg) 
Confectionary (including chocolate), as glazing agent only  500  500 
Chewing gum  1200  1200 
Small products of fine bakery wares coated with chocolate, as 
glazing agent only  200 200 
Snacks 200  200 
Nuts 200  200 
Coffee beans  200  200 
Food supplements   200  200 
Fresh citrus fruits, melons, apples, pears, peaches and pineapples 
(surface treatment only)  200 200 
 
                                                      
 
17 European Parliament and Council Directive 95/2/EC of 20 February 1995 on food additives other than colours and 
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2.7.  Information on existing authorisations and evaluations 
The SCF evaluated carnauba wax several times. In 1990 the SCF reviewed acute oral toxicity studies 
and dermal teratogenicity studies on carnauba wax not showing any treatment-related adverse effects 
(SCF, 1992). The SCF was unable to establish an ADI for carnauba wax but considered its use as 
glazing agent at the levels examined as temporarily acceptable until toxicological data and technical 
data on use levels have been provided (SCF, 1992). In 1994 SCF evaluated a 90-day rat toxicity study, 
a 28-week dog toxicity study, a combined reproductive and subchronic rat toxicity study, a rat 
teratogenicity study and in vitro mutagenicity studies in bacteria and yeast (SCF, 1997). The SCF was 
informed at that time that use of carnauba wax on confectionery was unlikely to exceed 200 mg/kg 
food, thus resulting in intakes unlikely to exceed 1-2 mg/kg bw/day. The SCF extended the temporary 
acceptance of carnauba wax as a glazing agent pending submission of in vitro chromosome aberrations 
tests in mammalian cells (SCF, 1997). Information was also requested on the readiness of carnauba 
wax ester components to hydrolyse. 
In 2001 the SCF reviewed new genotoxicity assay and supplementary information on usage levels of 
carnauba wax as a glazing agent submitted following its request in 1997 (SCF, 2001). The SCF 
decided to withdraw the temporary acceptance status of carnauba wax and accepted its use as a glazing 
agent up to a maximum use level of 200 mg/kg of food (SCF, 2001). In an addendum to the latter 
opinion, SCF considered a new request for use levels of carnauba wax of 500 mg/kg in confectionery 
(hard and soft sugar coated centers) and 1200 mg/kg in chewing gum as a glazing agent (SCF, 2002). 
The SCF did not object the use of carnauba wax as a glazing agent at higher levels in products 
requiring it. The SCF noted that a use level of 1200 mg/kg of food would yield a worst-case intake 
estimate of 48 mg/person/day which equates to 4.8 mg/kg bw/day for a 10 kg child, or less for an 
adult, and is within the ADI of 0-7 mg/kg bw set by the JECFA in 1993 (SCF, 2002). 
According to Directive 95/2/EC
2 carnauba wax (E 903) is authorised at defined maximum levels as a 
glazing agent only (Table 3). 
Carnauba wax is permitted with no specific restriction in plastics in contact with food as Ref No 
42720 (Directive 2002/72/EC
18). 
JECFA evaluated carnauba wax and based on short-term feeding studies in rats, a combined 
reproductive and developmental toxicity study in rats and in vitro mutagenicity studies, allocated an 
ADI of 0-7 mg/kg bw/day based on the highest dose tested in the combined study in rats (JECFA, 
1993).  
In the USA carnauba wax is classified as Generally Recognized as Safe (GRAS) and is permitted with 
no other limitation than good manufacturing practice (GMP) in a variety of food products (FDA, 
1983). Carnauba wax is permitted in Canada (http://www.hc-sc.gc.ca/fn-
an/securit/addit/diction/dict_food-alim_add-eng.php#c, accessed in June 2010), in Japan 
(http://www.ffcr.or.jp/zaidan/FFCRHOME.nsf/pages/list-exst.add, accessed in June 2010), and in 
Australia and New Zealand.  
Carnauba wax is used in the formulation of stick and solid cosmetics (e.g. lip stick balms and lotion 
bars), in face and eye makeup preparations, fragrance preparations, hair colouring and conditioning 
preparations, and skin care products (Anonymous, 1984). 
                                                      
 
18 Commission Directive 2002/72/EC of 6 August 2002 relating to plastic materials and articles intended to come into contact 
with foodstuffs. OJ L 220, 15.8.2002, p. 18. 
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2.8.  Exposure 
2.8.1.  Food consumption data used for exposure assessment 
In 2010, the EFSA Comprehensive European Food Consumption Database (Comprehensive Database) 
has been built from existing national information on food consumption at a detailed level. Competent 
authorities in the European countries provided EFSA with data on the level of food consumption by 
the individual consumer from the most recent national dietary survey in their country (cf. Guidance of 
EFSA ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure 
Assessment’ (EFSA, 2011b). 
Overall, the food consumption data gathered at EFSA were collected by different methodologies and 
thus direct country-to-country comparison should be made with caution. 
For calculation of chronic exposure, intake statistics have been calculated based on individual average 
consumption over the total survey period excluding surveys with only one day per subject. High level 
consumption was only calculated for those foods and population groups were the sample size was 
sufficiently large to allow calculation of the 95
th percentile (EFSA, 2011b). The Panel estimated 
chronic exposure for the following population groups: toddlers, other children, adolescents, and adults 
and the elderly. Calculations were performed using individual body weights. 
Thus, for the present assessment, food consumption data were available from 26 different dietary 
surveys carried out in 17 different European countries as mentioned in Τable 4:  
Table 4:  Population groups considered for the exposure estimates of carnauba wax 
Population  Age range  Countries with food consumption surveys 
covering more than one day 
Toddlers  from 12 up to and including 35 
months of age 
Bulgaria, Finland, Germany, Netherlands  
Children
19  from 36 months up to and including 
9 years of age  
Belgium, Bulgaria, Czech Republic, Denmark, Finland, 
France, Germany, Greece, Italy, Latvia, Netherlands, 
Spain, Sweden 
Adolescents  from 10 up to and including 17 years 
of age  
Belgium, Cyprus, Czech Republic, Denmark, France, 
Germany, Italy, Latvia, Spain, Sweden 
Adults  from 18 up to and including 64 years 
of age 
Belgium, Czech Republic, Denmark, Finland, France, 
Germany, Hungary, Ireland, Italy, Latvia, Netherlands, 
Spain, Sweden, UK 
The elderly
19   Older than 65 years  Belgium, Denmark, Finland, France, Germany, 
Hungary, Italy
 
Consumption records were codified according to the FoodEx classification system (EFSA, 2011a). 
Nomenclature from FoodEx classification system has been linked to the Food Classification System as 
presented in the Commission Regulation (EU) N° 1129/2011
20, part D, to perform exposure estimates. 
                                                      
 
19 The terms “children” and “the elderly” correspond respectively to “other children” and the merge of “elderly” and “very 
elderly” age groups in the EFSA Guidance on the ‘Use of the EFSA Comprehensive European Food Consumption Database 
in Exposure Assessment’ (EFSA, 2011b). 
20 Commission Regulation (EU) No 1129/2011 of 11 November 2011 amending Annex II to Regulation (EC) No 1333/2008 
of the European Parliament and of the Council by establishing a Union list of food additives. OJ L 295, 12.11.2011. Re-evaluation of carnauba wax (E 903) as a food addtive 
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2.8.2.  Exposure to carnauba wax from its use as food additive 
Exposure to carnauba wax from its use as a food additive has been calculated by using MPLs as listed 
in Table 3. Since no data different from the MPL were reported for normal use levels, no further 
refinement was calculated. 
High level exposure (95
th percentile of consumers only) was calculated by adding the 95
th percentile of 
exposure from one food group (i.e. the one having the highest value) to the mean exposure resulting 
from the consumption of all other food groups.  
This is based on the assumption that an individual might be a high level consumer of one food 
category and would be an average consumer of the others. This approach has been tested several times 
by the Panel in the re-evaluation of food colours and has shown reasonable correlation with high level 
total intakes when using the raw food individual consumption data. Therefore, this approach was 
preferred for the calculations based on the maximum reported use levels in order to avoid excessively 
conservative estimates.  
However, the Panel noted that its estimates should be considered as being conservative as it is 
assumed that all processed foods contain carnauba wax added at the MPLs. 
Table 5 summarises the estimated exposure to carnauba wax from its use as a food additive of all five 
population groups. 
2.8.3.  Main food groups contributing to exposure of carnauba wax using MPL 
The main contributors to the total anticipated mean exposure to carnauba wax for toddlers, children, 
adolescents and adults were fruits and confectionary. For toddlers fruits and confectionary contributed 
to 64-96% and 12-18% exposure, respectively, for children these contributions were 47-79% and 12-
18%, for adolescents 44-81% and 11-19%, and for adults 60-93% and 11%, respectively. For the 
elderly, the main contributors to the total anticipated mean exposure to carnauba wax were fruits (79-
95%). 
Table 5:  Summary of anticipated exposure to carnauba wax using the tiered approach (EC, 2001) 
in children and the adult population 
  Toddlers 
(12-35 months)
Children 
(3-9 years) 
Adolescents 
(10-17 years) 
Adults 
(>18 years) 
Elderly  
(> 65 years) 
 mg/kg  bw/day  mg/kg 
bw/day 
mg/kg bw/day  mg/kg bw/day  mg/kg bw/day 
Estimated exposure 
using MPL 
•  Mean exposure 
•  Exposure 95
th 
 
 
2.6-4.6 
3.1-8.1 
 
 
1.6-4.5 
3.2-7.6 
 
 
0.9-2.1 
1.9-3.8 
 
 
0.7-1.7 
1.5-3.0 
 
 
0.8-1.5 
1.9-2.7 
 
2.8.4.  Other sources 
Carnauba wax is used on pharmaceutical products (tablets) and in a range of technical applications 
like cosmetic, fragrance preparations, hair colouring and conditioning preparations, and manicuring, 
skin care, and suntan preparations. However, considering the chemical properties of the product it is 
unlikely that any significant systemic exposure will take place from these applications. Re-evaluation of carnauba wax (E 903) as a food addtive 
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3.  Biological and toxicological data  
3.1.  Absorption, distribution, metabolism and excretion  
No new data on absorption, distribution, metabolism and excretion were available for this re-
evaluation. 
Fatty acid esters 
The major constituents of carnauba wax are esters of acids and alcohols with average chain lengths of 
C26 to C32 (Table 1). Generally intact long-chain fatty acid esters are poorly absorbed.  
However, the alcohols and acids generated from the hydrolysis of carnauba wax constituents in the 
intestinal tract can be absorbed and incorporated into normal cellular metabolic pathways. 
3.2.  Toxicological data 
The Panel noted that toxicological studies were conducted on carnauba wax itself and therefore the 
components of carnauba wax have been tested in those studies. 
3.2.1.  Acute oral toxicity 
Two unpublished acute oral toxicity studies in rats have been briefly reported (Anonymous, 1984). 
Administration by gavage to 10 Sprague-Dawley rats of a 20 000 mg/kg dose of a lipstick formulation 
containing 5.6% carnauba wax (representing a dose of 1100 mg/kg of carnauba wax) did not show 
deaths or toxic effects (no further details). 
In a second study, oral intubation of five rats (strain unknown) with a blush formulation containing 
10% carnauba wax diluted to 33.3% in corn oil, making the wax concentration of 3.33%. None of the 
animals died when a 500 mg carnauba wax/kg bw was administered (Anonymous 1984). 
3.2.2.  Short-term and subchronic toxicity 
Groups of 15 male and 15 female Wistar rats, approximately 5 weeks of age at the beginning of the 
study, were fed diets containing 0, 1, 5 or 10% carnauba wax, or 10% cellulose powder for 13 weeks 
corresponding to 0, 800, 4200 and 8800 mg/kg bw/day for males and 0, 900, 4600 and 10 200 mg/kg 
bw/day for females (Rowland et al., 1982). The rats fed diets containing cellulose powder acted as a 
control group for possible effects due to the replacement of a significant proportion of the diet by a 
non-nutrient test material. Additional groups of five rats of each sex were fed diets containing 0, 5, 
10% carnauba wax or 10% cellulose powder for 2 and 6 weeks. Food consumption and body weights 
were recorded. Haematological, serum biochemistry, urinalysis, organ weights, and gross 
examinations were recorded at autopsy. Histopathological examinations were done on half of the 
tissue sections conserved from the control rats and tissues from those given 10% carnauba wax or 10% 
cellulose powder. Results showed a significant increase in mean food consumption in male and female 
rats given 10% carnauba wax or 10% cellulose powder, without statistically significant differences in 
body weights compared to controls. A higher erythrocyte count at week 2 in male rats fed 10% 
carnauba wax was noticed, but no other statistical significant differences were recorded on 
haematological findings in rats fed diet containing 10% carnauba wax at 2, 6 or 13 weeks. Glutamic-
oxalacetic transaminase, glutamine-pyruvic transaminase and lactic dehydrogenase activities in serum 
were similar in treated and control animals. Few significant random differences in urinalysis (specific 
gravity, volume) were recorded. Organ weights did not show changes related to carnauba wax doses. 
Histopathological examination reported some inflammatory cell infiltration and few areas of focal Re-evaluation of carnauba wax (E 903) as a food addtive 
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necrosis in the liver, as well as some interstitial pneumonitis with similar incidences in 10% carnauba 
wax and 10% cellulose powder treated animals (Rowland et al., 1982). A No Observed Adverse Effect 
Level (NOAEL) of 8800 mg/kg bw/day can be derived by the Panel from this study, the highest dose 
tested in male rats. 
In a modified 90-day toxicity feeding study carried out to investigate “bioaccumulation” of carnauba 
wax, groups of 20 male and 20 female Fischer F-344 rats were fed diets containing carnauba wax 
corresponding to daily intakes of 0, 15, 150 and 1500 mg/kg bw, respectively, continuously for 90 
days (main study) (Edwards, 1998). Additional two groups of 5 male and 5 female Fischer F-344 rats 
were assigned to a reversibility phase in which animals fed the control diet and a diet of 1500 mg/kg 
bw/day of carnauba wax for 90 days were reverted to control diet for additional 90 days. 
Observations throughout the study included general condition and behaviour, body weight, food 
intake, ophthalmological observations, haematological examination, blood clinical chemistry and 
organs weight. Histological examination was conducted on selected organs after at least 90 days of 
treatment. Tissues from animals from the reversibility phase were not examined. A single female in 
the highest dosage group died spontaneously of brain haemorrhage on day 52 (Edwards, 1998). 
The most frequent finding in the main study was that of red staining in the head region, which was 
observed in all groups, including controls. In the animals from the reversibility phase minor 
observations included red staining in the head region, areas of fur loss or unkempt fur and yellow 
staining in urinogenital areas, occurring in both treated and control groups. Given the similar patterns 
observed in both treated and control groups it was considered that no treatment-related adverse 
findings related to the condition and behaviour were observed (Edwards, 1998).  
Among several endpoints, necropsied tissues such as heart, liver, kidney, spleen, lymph nodes and 
ileum, were microscopically evaluated. From these observations, the authors concluded that no 
evidence of lipid accumulation derived from carnauba wax was noted (Edwards, 1998).  
The body weights of the male animals were not statistically significantly different from the controls. 
For females, no marked differences from the controls were reported except for a significantly higher 
mean body weight of the females in the 15 mg/kg group at days 3 to 10. This difference disappeared 
by study day 14 and was thus considered as not treatment-related. No differences in mean body 
weights of male or female rats were reported after the reversibility phase of the study. During the 
study the feed intake of male and female rats fed carnauba wax was significantly higher in some 
animals at all doses tested compared to the controls. This finding was not considered to be an adverse 
effect and it might reflect feed compensation from increasing proportions of non-nutrient carnauba 
wax containing diets. No differences in feed intake were reported after the reversibility phase of the 
study. No abnormalities were reported upon ophthalmological examination. Occasional statistically 
significant differences in haematological findings and clinical chemistry parameters were observed in 
male or female rats. These changes were not dose related and were thus considered as not treatment 
related. No marked differences in these parameters were reported in animals after the reversibility 
phase of the study. Serum chemistry analysis showed slight occasional changes in clinical chemistry 
from animals in the 15 and 150 mg/kg bw/day carnauba wax groups not observed in the 1500 mg/kg 
bw/day group (lower chloride or protein concentration, higher albumin/globulin ration, higher alanine 
aminotransferase and lactate dehydrogenase activities). Few differences were reported in animals after 
the reversibility phase of the study (Edwards, 1998). 
The only differences found in organ weights in male rats were inconsistent increases in the mean 
absolute weight of the brain of the group fed 15 mg/kg bw/day carnauba wax and a reduction in the 
mean relative weight of the thymus in the 15 and 1500 mg/kg bw/day groups. No statistically 
significant differences in any organ weight were reported in females. Upon histopathological 
examination the only finding reported was higher incidences of individual cell necrosis in the liver of 
male rats in the 15 and 150 mg/kg bw groups; in the latter, a significant higher incidence of 
vacuolisation in the liver of male rats was also reported, but the 1500 mg/kg bw/day animal group did Re-evaluation of carnauba wax (E 903) as a food addtive 
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not show these effects. No significant differences in histopathological findings were observed in the 
females. Overall, the histopathological examination of tissues taken at necropsy did not show any 
treatment related adverse findings (Edwards, 1998). The Panel identified a NOAEL of 1500 mg/kg 
bw/day from this study, the highest dose tested.  
Four groups of 6 male and 6 female Beagle dogs were fed diets containing 0, 0.1, 0.3 or 1% carnauba 
wax for 28 weeks (equivalent to 25, 75 or 250 mg/kg bw/day) (Parent et al., 1983a). Food 
consumption, body weights and behavioural effects were recorded weekly. Blood and urinary samples 
were collected at weeks 11 and 26. Organs were weighed (brain, pituitary gland, thyroid gland, heart, 
liver, spleen, kidneys, and adrenal glands), and gross and microscopic examinations of tissues were 
performed at the end of the study. No significant differences in body weights or food consumption 
were noted between treatment and control groups of animals. Data from serum biochemistry, 
urinalysis and organ weights did not show any treatment-related effects in dogs consuming carnauba 
wax. The only significant (p <0.05) clinical observation at 26 weeks were the higher free fatty acid 
levels only in male dogs at all dietary levels of carnauba wax as compared to controls. Observations 
made after 11 weeks were comparable between groups. The authors noted that serum free fatty acid 
levels in this study were increased in male dogs at all doses of carnauba wax tested as compared to 
controls. However, the authors noticed that serum free fatty acid levels in treated male dogs remained 
within the normal historical range for Beagle dogs from the laboratory (200-800 µM/l), whereas the 
values in the controls in this study were comparatively lower (138 ± 38 µM/l) than the historical 
values. Ophthalmologic and gross examinations revealed no significant treatment-related effects for up 
to 1% carnauba wax in the diet. Histopathological findings were reported comparable between groups 
including controls (Parent et al., 1983a). A NOAEL of 250 mg/kg bw/day could be derived by the 
Panel from this study, the highest dose tested. 
3.2.3.  Genotoxicity 
Genotoxicity of carnauba wax was considered by JECFA during its evaluation (JECFA, 1993). The 
results from the studies available at that time were reported as summary only and the study reports 
were not available for this re-evaluation. Available information from the JECFA report is reproduced 
below in Table 5.  
Table 5:  JECFA summary of the results of mutagenic studies on carnauba wax (from JECFA, 
1993) 
End-point Test  system  Concentration  of 
Carnauba wax 
Results References 
Reverse 
mutation
1 
S. typhimurium TA1537, 
TA1538, TA98 
3.3-1000 µg in plate tests  Negative  (Mortelmans  and 
Griffin, 1981) 
Reverse 
mutation
1 
S. typhimurium TA1537, 
TA1538, TA98 
0.01-0.5% in suspension 
tests 
Negative (Mortelmans  and 
Griffin, 1981) 
Reverse 
mutation
1 
S. typhimurium TA1537, 
TA1538, TA98 
0.1-2.5% in suspension tests  Negative  (Mortelmans  and 
Griffin, 1981) 
Reverse 
mutation
2 
S. typhimurium TA1535, 
TA1537, TA1538 
0.01% in plate tests  Negative  (Litton  Bionetics 
inc, 1975) 
Reverse 
mutation
2 
S. typhimurium TA1535, 
TA1537, TA1538 
0.005 and 0.01% in 
suspension tests 
Inconsistent 
changes
3 
(Litton Bionetics 
inc, 1975) 
Gene 
conversion
2 
S. cerevisiae D4  0.3 and 1.75% in suspension 
tests
Negative (Litton  Bionetics 
inc, 1975) 
1 The Ames/Salmonella assays in the presence and absence of an Aroclor 1254-stimulated, rat-liver homogenate metabolic 
activation system, were used in this study.
 
2 A series of in vitro microbial assays with and without metabolic activation were used. In the activation assays, the tissue 
homogenate of liver, lung and testes were prepared from either mouse, rat or monkey.
 Re-evaluation of carnauba wax (E 903) as a food addtive 
 
EFSA Journal 2012;10(10):2880  16
3 The results from non-activation suspension tests were negative. The results from activation suspension tests showed 
scattered increased mutation responses in the presence of rat-liver or testes homogenate with strain TA1537, and in the 
presence of monkey-lung homogenate with TA1538. 
Additional data considered in the SCF evaluation consisted of an in vitro chromosomal aberration tests 
with carnauba wax were performed using human lymphocytes without S-9 mix for 20 hours treatment, 
and with S-9 mix (10% v/v and Aroclor 1254 induced) for 3 hours treatment (Edwards, 1996; 1997). 
According to the authors, since the test article was not soluble in culture medium or in other tested 
vehicles commonly used, preliminary studies were carried out on two vehicles: soybean oil and 
chloroform/DMSO mixtures. Human lymphocytes cultures were treated with those vehicles to 
determine the maximum concentrations not causing toxicity or chromosome damage. The results 
showed that the suspension of carnauba wax in 10% soybean oil and emulsification in culture medium 
was the method of choice. The test article was then suspended in soybean oil and was emulsified in 
culture medium. Initially, two chromosome aberration tests were conducted, each employing cultures 
treated in duplicate with a range of 5 concentrations of carnauba wax together with untreated, vehicle 
and positive controls. Cells were treated 3 hours with metabolic activation and harvested 20 hours 
after culture initiation. Without metabolic activation, a continuous treatment of 20 hours was applied. 
The experiment was repeated with an extra 44 hours harvest time for the highest test concentration 
without S-9 mix. Concentrations of 0.031, 0.063, 0.125, 0.25 and 0.5 mg carnauba wax/ml were tested 
in those experiments (Edwards, 1996; 1997).  
In the first chromosome aberration test without metabolic activation, no statistically significant 
increases in aberrant metaphases, including or excluding gaps, were reported with the vehicle (control) 
or any test article concentration compared with the untreated control in the absence of S9 activation. 
But a statistically significant positive linear trend without gaps was reported for test article treatments 
and the untreated control. No significant trend was reported with gaps. A reverse pattern of responses, 
i.e. a significant linear trend only with gaps, was observed in the presence of S9 activation in this 
chromosome aberration test (Edwards, 1996).  
In a second chromosome aberration test, no statistically significant increases in aberrant metaphases or 
linear trend, including or excluding gaps, were reported in the absence or presence of S9 activation 
(Edwards, 1996). However, in this trial a borderline response (p=0.053) was elicited by 
cyclophosphamide, the positive control substance in presence of metabolic activation. 
To account for a low response noted in the positive control in the second chromosome aberration test, 
a third chromosomal aberration test was done under the same conditions as described above (Edwards, 
1997). In this test the positive control (cyclophosphamide 10 µg/ml) gave statistically significant 
increase in aberrant metaphases, including or excluding gaps, whereas no statistically significant 
increases in aberrant metaphases or linear trend, including or excluding gaps, were reported with the 
test article in the presence and absence of S9 activation (Edwards, 1997). Overall, carnauba wax 
assayed at the maximum practicable concentration in vitro, although in the absence of sufficient 
cytotoxicity is not regarded to cause structural chromosome aberrations in vitro under the reported 
experimental conditions. No in vivo genotoxicity data were available on carnauba wax.  
The Panel observed that although that there are limitations in testing insoluble compounds in vitro, 
based on the available data, the methodology used in the study  and the lack of structural alerts on 
carnauba wax it can be concluded that there is no concern for genotoxicity. 
3.2.4.  Chronic toxicity and carcinogenicity 
No studies on chronic toxicity or carcinogenicity were available on carnauba wax. Re-evaluation of carnauba wax (E 903) as a food addtive 
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3.2.5.  Reproductive and developmental toxicity 
In a reproduction study in rats, four groups of 25 female (F0) and 25 male Wistar rats were 
administered 0, 0.1, 0.3 or 1% carnauba wax in the diet (Parent et al., 1983b). This administration 
equals 0, 80, 250, or 810 mg carnauba wax/kg bw/day for males and 0, 90, 270, or 670 mg carnauba 
wax/kg bw/day for females as calculated by the authors from of food consumption over the entire 
study (Parent et al., 1983). After 4 weeks of feeding, all F0 generation rats were paired within the 
groups. Test diets were continued throughout mating, gestation and lactation. F1 generation was 
produced from F0 females and at day 21 post-partum animals were randomly selected to form the F1 
generation. F1 animals (25 of each sex/group) continued to receive the same diet as its F0 for 13 
additional weeks. 
Observations throughout the study included food intake, body weights, ophthalmological 
observations, haematological examination, blood clinical chemistry and organs weight. Complete 
gross necropsies were performed on all F0 animals, F1 animals that were killed after weaning, and F1 
animals used for the post-weaning 13-week feeding study. Histological examination was performed on 
selected organs of animals in the control and high dose groups. For animals in the low and mid-dose 
groups, only grossly abnormal tissues were examined microscopically (Parent et al., 1983b).  
Indices of fertility, gestation, viability, and lactation, or pup weights were not statistically significantly 
affected by the treatments. Nor were the number of born alive or born dead pups per litter although a 
decreased total number of pups was noticed in the treated groups (between 228 and 230 pups) 
compared to controls (269 pups). There were no statistically significant differences on body weight 
gain reported amongst the groups. Inconsistent differences in food consumption between the groups 
were mentioned by the authors without details (Parent et al., 1983b). 
Haematology and urine analysis from F1 generation showed statistically significant increase in 
haematocrit of female rats fed diets containing 0.1% and 1% carnauba wax but not in the 0.3% group. 
Males did not show any change in haematology parameters measured. Blood clinical chemistry 
showed in males significantly increased nitrogen urea levels at the highest dose tested and increased 
chloride levels at the two highest doses tested (0.3% and 1.0%). Decreased levels of serum glutamate-
pyruvate transaminase and free fatty acid levels were also reported at these doses. In female rats blood 
clinical chemistry only showed decreased levels in free fatty acids at the two highest doses tested, the 
rest of the clinical chemistry parameters measured did not differ amongst the groups. 
Organ weights measured in male or female animals were not affected by the treatments and 
microscopic examination of tissues and organs did not reveal any treatment-related effects (Parent et 
al., 1983b). A NOAEL of 670 mg/kg bw/day could be derived by the Panel from this study, the 
highest dose tested in female rats. 
This study was used by JECFA as the basis for setting the ADI of 7 mg/kg bw/day for carnauba wax 
(rounded up), by applying a 100 uncertainty factor to the NOAEL of approximately 670 mg/kg 
bw/day. 
Special study on developmental toxicity 
JECFA briefly reports one developmental toxicity study done with Wistar rats (FDRL, 1977; as 
reported by JECFA, 1993). Four groups of 25 females, were fed 0, 0.1, 0.3 or 1% carnauba wax in the 
diet for two weeks before mating and throughout gestation (equivalent to 0, 50, 150, or 500 mg/kg 
bw/day). Body weights of pregnant dams were recorded on days 0, 6, 11, 15, and 20 of gestation. On 
day 20 of gestation caesarean sections were performed on pregnant females, and gross pathological 
changes were noted. The uterine contents were examined and the number of corpora lutea, 
implantation sites, resorption sites, live and dead fetuses, gross malformations, and body weights of 
live fetus were recorded. One-half of fetuses were examined for signs of visceral pathological changes 
and the other half were examined for signs of skeletal abnormalities. JECFA reports that there were no Re-evaluation of carnauba wax (E 903) as a food addtive 
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significant changes in body weights of pregnant dams during gestation, no significant differences in 
reproduction data among test groups, and no dose-related effects of carnauba wax on skeletal or soft 
tissue development in fetus (JECFA, 1993). The original study report was not available to the Panel.  
3.2.6.  Allergenicity, hypersensitivity and intolerance 
No information relevant to carnauba was exposure via the oral route was identified by the Panel. 
4.  Discussion  
The Panel was not provided with a newly submitted dossier and based its evaluation on previous 
evaluations, additional literature that became available since then and the data available following a 
public call for data. The Panel noted that not all original studies on which previous evaluations were 
based were available for re-evaluation by the Panel.  
Carnauba wax has been evaluated by the Scientific Committee on Food (SCF, 1992; 1997; 2001; 
2002) and by the Joint FAO/WHO Expert Committee on Food Additives (JECFA, 1993). JECFA 
allocated an Acceptable Daily Intake (ADI) of 0-7 mg/kg bw/day (JECFA, 1993). The Panel noted 
that toxicological studies were conducted on carnauba wax and therefore the large majority of 
components of carnauba wax have been tested. 
Carnauba wax (E 903) is a complex mixture consisting of aliphatic esters (wax esters), α-hydroxyl 
esters and cinnamic aliphatic diesters. It also contains free acids, free alcohols, hydrocarbons and 
resins. It is obtained from the leaf buds and leaves of the Brazilian Mart wax palm, Copernicia 
cerifera (EU, 2008). It is described as consisting mainly of straight-chain acids with even-numbered 
carbon chains from C24 to C28 and straight-chain alcohols with even-numbered carbon chains from C30 
to C34 (JECFA, 1998). The average composition of the highest quality carnauba wax has been reported 
as consisting primarily of 40% (w/w) aliphatic esters, 21% (w/w) diesters of 4-hydroxycinnamic acid, 
13% (w/w) esters of ω-hydroxycarboxylic acids and 12% (w/w) free alcohols (Wolfmeier et al., 2005).  
Specifications have been defined in the Directive 2008/84/EC and new specifications according to 
Commission Regulation (EU) No 231/2012 will apply from 1
st December 2012.  
One modified 90-day toxicity feeding study carried out to investigate “bioaccumulation” of carnauba 
wax in Fischer F-344 rats indirectly suggested that the lipid like components from the wax are not 
accumulated in the tissues (Edwards, 1998). Overall, taking into consideration also the chemical 
composition of carnauba wax, the Panel considered, as with other natural waxes, that absorption of 
carnauba wax is expected to be low, if any. 
From a 13-weeks study with groups of 15 male and 15 female Wistar rats, approximately 5 weeks of 
age at the beginning of the study, fed diets containing 0, 1, 5 or 10% carnauba wax, or 10% cellulose 
powder for 13 weeks (corresponding to 0, 800, 4200 and 8800 mg/kg bw/day for males and 0, 900, 
4600 and 10 200 mg/kg bw/day for females) (Rowland et al., 1982).The Panel could derive a NOAEL 
of 8800 mg/kg bw/day, the highest dose tested in male rats. 
From a 28-week study with four groups of 6 male and 6 female Beagle dogs fed diets containing 0, 
0.1, 0.3 or 1% carnauba wax (equivalent to 25, 75 or 250 mg/kg bw/day) (Parent et al., 1983a) the 
Panel could derive a NOAEL of 250 mg/kg bw/day, the highest dose tested. 
From a 90-day toxicity study with groups of 20 male and 20 female Fischer F-344 rats fed diets 
containing carnauba wax corresponding to daily intakes of 0, 15, 150 and 1500 mg/kg bw, 
respectively, continuously for 90 days (Edwards, 1998) the Panel could derive a NOAEL of 1500 
mg/kg bw/day, the highest dose tested. Re-evaluation of carnauba wax (E 903) as a food addtive 
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The Panel considered that based on the available data and the lack of structural alerts on carnauba wax 
it can be concluded that there is no concern for genotoxicity for carnauba wax.  
No chronic toxicity or carcinogenicity studies were available on carnauba wax, however in its 1994 
opinion the SCF already noted that the structure of the main components of carnauba wax (long-chain 
aliphatic esters) raises the possibility that it might behave like some mineral hydrocarbons (SCF, 
1994).  
From a reproductive toxicity study of carnauba wax with groups of 25 female and 25 male Wistar rats 
administered 0, 0.1, 0.3, or 1% carnauba wax in the diet (Parent et al., 1983) the Panel could derive a 
NOAEL of approximately 670 mg carnauba wax/kg bw/day, the highest dose tested in female rats.  
Exposure estimates reported for carnauba wax, when considering MPLs, result in a mean dietary 
exposure of European toddlers (aged 12-35 months and weighing an average of 15 kg) ranged from 
2.6-4.6 mg/kg bw/day, and from 3.1-8.1 mg/kg bw/day at the 95
th percentile. The mean dietary 
exposure of European children (aged 3-9 years and weighing an average of 30 kg) ranged from 1.6-4.5 
mg/kg bw/day, and from 3.2-7.6 mg/kg bw/day at the 95
th percentile. The main contributors to the 
total anticipated mean exposure to carnauba wax for these populations were fruits and confectionary. 
The mean dietary exposure of European adolescents (aged 10-17 years and weighing an average of 50 
kg) ranged from 0.9-2.1 mg/kg bw/day, and from 1.9-3.8 mg/kg bw/day at the 95
th percentile. The 
main contributors to the total anticipated mean exposure to carnauba wax for this population were 
fruits and confectionary. Whereas the mean dietary exposure of the European adult population give a 
mean dietary exposure in the range of 0.7-1.7 mg/kg bw/day and 1.5-3.0 mg/kg bw/day for high level 
consumers. The main contributors to the total anticipated mean exposure to carnauba wax for this 
population were fruits and confectionary. For the elderly, mean exposure to carnauba wax was in the 
range of 0.8-1.5 mg/kg bw/day and in the range of 1.9-2.7 mg/kg bw/day at the 95
th percentile. Main 
contributors for these populations groups were fruits. 
From the highest consumers of these populations (95
th percentile) these exposures estimates would 
result in margins of safety from 83 to 447 when compared to the NOAEL of 670 mg/kg bw/day 
identified in a reproductive toxicity study with rats by Parent (Parent et al., 1983a), from 31 to 167 
when compared to the NOAEL of 250 mg/kg bw/day identified in a subchronic toxicity study with 
dogs by Parent (Parent et al., 1983b), from 185 to 1000 when compared to the NOAEL of 1500 mg/kg 
bw/day identified in a subchronic toxicity study with rats by Edwards (Edwards et al., 1998), and from 
1086 to 5867 when compared to the NOAEL of 8800 mg/kg bw/day identified in a subchronic toxicity 
study with rats by Rowland (Rowland et al., 1982). These margins of safety are considered sufficient 
by the Panel taking into consideration that the NOAEL’s identified are the highest dose tested not 
showing any effect in their respective studies, and that the exposure estimates to carnauba wax carried 
out in this opinion are very conservative. 
Overall, the Panel considered that long-term toxicity data on carnauba wax were lacking and therefore 
did not establish an ADI. 
However, the Panel noted that available toxicity studies consistently reported no findings associated 
with carnauba wax intake. Furthermore, consideration of the conservative exposure estimates to 
carnauba wax from the currently authorised uses indicated sufficient margins of safety, which allowed 
the Panel to consider that the use of carnauba wax as a food additive with the currently authorised uses 
would not be of safety concern. 
CONCLUSION 
Carnauba wax has been evaluated by the Scientific Committee on Food (SCF, 1992; 1997; 2001; 
2002) and by the Joint FAO/WHO Expert Committee on Food Additives (JECFA, 1993). JECFA Re-evaluation of carnauba wax (E 903) as a food addtive 
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allocated an Acceptable Daily Intake (ADI) of 7 mg/kg bw/day (JECFA, 1993). The SCF did not 
establish an ADI but did not object to use of carnauba wax as a glazing agent (SCF, 2002).  
Overall, the Panel concluded that long-term toxicity data on carnauba wax were lacking and therefore 
did not establish an ADI.  
However, the Panel noted that available toxicity studies consistently reported no findings associated 
with carnauba wax intake. Furthermore, consideration of the conservative exposure estimates to 
carnauba wax from the currently authorised uses indicated sufficient margins of safety, which allowed 
the Panel to conclude that the use of carnauba wax as a food additive with the currently authorised 
uses would not be of safety concern. 
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1.  Pre-evaluation document prepared by the Technical University of Denmark (DTU). September 
2010. 
2.  European Wax Federation. Data on waxes permitted as food additives. April 2010. 
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GLOSSARY AND ABBREVIATIONS 
ADI  Acceptable Daily Intake  
ANS Scientific  Panel  on  Food Additives and Nutrient Sources added to Food 
BIBRA British  Industrial  Biological Research Association  
CAS RN   Chemical Abstracts Service Registry Number 
EC European  Commission   
EFSA  European Food Safety Authority 
FAO  Food and Agriculture Organization of the United Nations 
GRAS  Generally Recognized as Safe  
JECFA  Joint Expert Committee on Food Additives 
MPL Maximum  permitted  use  level 
NOAEL No-Observed-Adverse-Effect-Level   
SCF Scientific  Committee  on  Food 
WHO   World Health Organization  
 